A neurophysiological biomarker called the spectral exponent (SE), which measures the steepness of the aperiodic (1/f) slope of EEG activity, can help distinguish levels of consciousness in patients with disorders of consciousness (DoC). In a study of 15 DoC patients, 9 conscious brain-injured controls, and 23 healthy controls, narrowband SE (1-20 Hz) differentiated DoC patients from controls and minimally conscious from vegetative/unresponsive states. SE correlated positively with behavioral scores on the CRS-R, particularly the visual subscale. Longitudinal tracking in one patient showed a reduction in SE negativity, flattening of the 1/f slope, and parallel behavioral recovery. The SE offers an objective complement to subjective behavioral assessments.
A Chinese version of the Near-Death Experience Content (NDE-C) scale was translated and validated on 79 near-death experience testimonies. The translation used Brislin's back-translation model, and the scale showed good internal consistency (Cronbach's α = 0.846). Confirmatory factor analysis supported the scale's structure. This new Chinese NDE-C scale is now available to screen people who have had near-death experiences or near-death-like experiences (e.g., from meditation) and to quantify their subjective experiences, enabling further research on this phenomenon in Eastern cultural contexts.